Phosphorex Participates in the LNP Formulation & Process Development Summit 2026

Phosphorex recently participated in the LNP Formulation & Process Development Summit in Boston, joining industry leaders and innovators for discussions focused on the future of lipid nanoparticle development, formulation optimization, process development, and scalable manufacturing.

Representing Phosphorex at the event were:

• Jerry Williamson – Chief Executive Officer
• Evan Turek – Senior Director, Business Development
• Aditya (Adi) Kulkarni, PhD – Business Development Director
• Irodiel Vinales Lozano, PhD – Senior Scientist

Throughout the event, the team engaged with peers across the industry on topics ranging from formulation strategy and analytical considerations to scale-up and translational development challenges for advanced therapeutics.

As interest in LNP-based therapeutics continues to grow, Phosphorex remains committed to supporting innovators through integrated formulation, process development, analytical, and delivery expertise designed to help advance complex programs from early development through clinical readiness.

If you did not have an opportunity to connect with the team during the event, we welcome the opportunity to continue the conversation.

Visit our website and follow us on LinkedIn to learn more about our capabilities and approach to precision drug delivery.